Please login to the form below

Not currently logged in
Email:
Password:

Hutchison MediPharma

This page shows the latest Hutchison MediPharma news and features for those working in and with pharma, biotech and healthcare.

Lilly enters cancer collaboration in China

Lilly enters cancer collaboration in China

Lilly will work with Chi-Med's research-focused subsidiary Hutchison MediPharma to investigate fruquintinib (HMPL-013), a small molecule to inhibit the vascular endothelial growth factor (VEGF) receptor tyrosine kinases. ... Both companies will share

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch table for October 2013 Deal Watch table for October 2013

    Asset acquisition. Mesenchymal stem cell business, including Prochymal (approved). 100. † Hutchison MediPharma / Eli Lilly.

  • Pharma deals during October 2013 Pharma deals during October 2013

    Focusing on China, Lilly has entered into a licence and co-development agreement with Hutchison MediPharm a for fruquintinib (HMPL-013), a phase II inhibitor of all three forms of Vascular ... Hutchison MediPharma will continue the development of

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics